CC0000: Color is not claimed as a feature of the mark.
D10000: PHARMACEUTICALS
GS0051: Medical diagnostic and therapeutic preparations, all for administration via diverse routes of administration including through the respiratory airways, and, medical devices for administering the pharmaceuticals, sold filled, the preparations including nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms; pharmaceutical preparations for testing, and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasconconstriction, inflammation, allergies, impeded respiration, acute respiratory disease syndrome (ARDS), renal damage and failure, ischemia resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating supra ventricular tachycardia (SVT), adenosine stress tests, infantile respiratory distress syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasconcontriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as metastatic cancers, eg, cancers which metastasized to the lung(s), breast, liver and prostate
Case File Event Statements
10/27/2008 - 16 years ago
32 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDType:MAB6
10/27/2008 - 16 years ago
31 - ABANDONMENT - NO USE STATEMENT FILEDType:ABN6
4/4/2008 - 16 years ago
30 - EXTENSION 5 GRANTEDType:EX5G
3/14/2008 - 16 years ago
29 - EXTENSION 5 FILEDType:EXT5
3/14/2008 - 16 years ago
28 - TEAS EXTENSION RECEIVEDType:EEXT
9/26/2007 - 17 years ago
27 - EXTENSION 4 GRANTEDType:EX4G
9/13/2007 - 17 years ago
26 - EXTENSION 4 FILEDType:EXT4
9/13/2007 - 17 years ago
25 - TEAS EXTENSION RECEIVEDType:EEXT
6/28/2007 - 17 years ago
24 - EXTENSION 3 GRANTEDType:EX3G
3/20/2007 - 17 years ago
23 - EXTENSION 3 FILEDType:EXT3
3/20/2007 - 17 years ago
22 - TEAS EXTENSION RECEIVEDType:EEXT
10/24/2006 - 18 years ago
21 - EXTENSION 2 GRANTEDType:EX2G
9/22/2006 - 18 years ago
20 - EXTENSION 2 FILEDType:EXT2
9/22/2006 - 18 years ago
19 - TEAS EXTENSION RECEIVEDType:EEXT
4/28/2006 - 18 years ago
18 - EXTENSION 1 GRANTEDType:EX1G
3/24/2006 - 18 years ago
17 - EXTENSION 1 FILEDType:EXT1
3/24/2006 - 18 years ago
16 - TEAS EXTENSION RECEIVEDType:EEXT
9/27/2005 - 19 years ago
15 - NOA MAILED - SOU REQUIRED FROM APPLICANTType:NOAM
7/5/2005 - 19 years ago
14 - PUBLISHED FOR OPPOSITIONType:PUBO
6/15/2005 - 19 years ago
13 - NOTICE OF PUBLICATIONType:NPUB
3/28/2005 - 19 years ago
12 - LAW OFFICE PUBLICATION REVIEW COMPLETEDType:PREV
3/25/2005 - 19 years ago
11 - ASSIGNED TO LIEType:ALIE
3/18/2005 - 19 years ago
10 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
3/17/2005 - 19 years ago
9 - AMENDMENT FROM APPLICANT ENTEREDType:ACEC
1/31/2005 - 20 years ago
8 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
1/31/2005 - 20 years ago
7 - PAPER RECEIVEDType:MAIL
10/5/2004 - 20 years ago
6 - TEAS CHANGE OF CORRESPONDENCE RECEIVEDType:TCCA